Sepsis Prevalence and Associated Hospital Admission and Mortality after Ureteroscopy in Employed Adults

Naeem Bhojani,Brian Eisner,Manoj Monga,Rutugandha Paranjpe,Ben Cutone,Ben H. Chew
DOI: https://doi.org/10.1111/bju.16029
2023-04-16
BJU International
Abstract:Objective To determine 30‐day inpatient mortality, intensive care unit (ICU) admissions, inpatient admissions/readmissions, and yearly trends in sepsis prevalence and inpatient mortality after ureteroscopy (URS) in employed adults. Materials and Methods We performed a retrospective analysis of the IBM MarketScan Commercial Database to identify employed adults aged 18 to 64 years who underwent URS from 2015 to 2019. Patients were categorized as no sepsis (controls), non‐severe sepsis, or severe sepsis within 30 days of URS. Main outcomes included inpatient mortality, ICU admissions, inpatient admissions, readmissions, and annual rates of sepsis and associated inpatient mortality. Results Among 109,496 patients undergoing URS, 5.6% developed sepsis (4.1% non‐severe; 1.5% severe). The 30‐day inpatient mortality rate was 0.03%, 0.3%, and 2.5% for controls, non‐severe sepsis, and severe sepsis, respectively (p<0.001). In a multivariable analysis, diagnosis of sepsis regardless of severity (hazard ratio=17.2; 95% CI: 10.5‐28.1; p 0.001) or severe sepsis (hazard ratio=49.5; 95% CI: 28.9‐84.7; p<0.001) increased the risk of 30‐day inpatient mortality compared to controls. ICU admissions on the day of procedure (1.5%, 19.8% and 52.4%), inpatient admission rates (18.3%, 74.9%, and 76.9%), and readmission rates (7.1%, 12.0% and 15.9%) were higher with severe sepsis and non‐severe sepsis vs controls (all p<0.001). During the study period, the prevalence of sepsis after URS increased from 4.7% to 6.6% (p
urology & nephrology
What problem does this paper attempt to address?